Article
DARPin-fused Tcell engager for adenovirus-mediated cancer therapy.
Molecular therapy. Oncology · 2024 · D. Brucher, PC. Freitag, M. van Gogh, KP. Hartmann, J. Kolibius, H. Laubli, A. Pluckthun, R. Weber, R. Wieboldt
Key facts
| Title | DARPin-fused Tcell engager for adenovirus-mediated cancer therapy. |
|---|---|
| First author | D. Brucher, PC. Freitag, M. van Gogh, KP. Hartmann, J. Kolibius, H. Laubli, A. Pluckthun, R. Weber, R. Wieboldt |
| Journal | Molecular therapy. Oncology |
| Published | May 29, 2024 |
| DOI | 10.1016/j.omton.2024.200821 |
| PubMed ID | 39021370 |
| PMC ID | PMC11253662 |
| Devices mentioned | 200821 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1